| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2006 | US20060205948 such as 2-(2-chloro-phenyl)-5-isopropyl-3-(3,4,5-trifluoro-phenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one; for treatment of eating disorders and psychological disorders |
| 09/14/2006 | US20060205946 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205945 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/14/2006 | US20060205941 Antiinflammatory agents; inflammatory bowel disorders |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060205826 Method of using carotenoids in the prevention of cognitive decline and for other neuroprotection functions |
| 09/14/2006 | US20060205825 Method for the preparation of sevoflurane |
| 09/14/2006 | US20060205824 Chiral integrin modulators and methods of use thereof |
| 09/14/2006 | US20060205823 Treatment of allergic diseases using a modulator of the Notch signaling pathway |
| 09/14/2006 | US20060205822 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect |
| 09/14/2006 | US20060205821 Enantiomers of N-desmethyl venlafaxine |
| 09/14/2006 | US20060205820 Formulations of anthraquinone derivatives |
| 09/14/2006 | US20060205819 Methods of treatment inflammatory bowel with lxr agonists |
| 09/14/2006 | US20060205818 Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives |
| 09/14/2006 | US20060205817 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof |
| 09/14/2006 | US20060205816 Phenyl substitited lactone; prepared in optically pure form from meso-fiydrobenzoin; chemical intermediate for alpha -hydroxy acids and 1,2-diols using catalytic hydrogenation |
| 09/14/2006 | US20060205815 Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition |
| 09/14/2006 | US20060205814 Administering mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester; cardiovascular disorders; administered along with ACE-, NEP-, or phosphodiesterase inhibitors; diuretics, positive inotropic drugs, vasodilators, beta-blockers, digitalis glycosides |
| 09/14/2006 | US20060205813 Novel 3,4-dihydroxyhydrocinnamic acid derivative |
| 09/14/2006 | US20060205812 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 09/14/2006 | US20060205811 Compounds that stimulate glucose utilization and methods of use |
| 09/14/2006 | US20060205810 Platinum therapeutic combinations |
| 09/14/2006 | US20060205809 Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 09/14/2006 | US20060205808 Anti-inflammatory and cure for ageing, Alzheimer's disease on phloroglucinol derivatives |
| 09/14/2006 | US20060205807 Amino-chroman compounds and methods for preparing same |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205805 Crystalline polymorphic forms; storage stability, thermostability, solubility |
| 09/14/2006 | US20060205804 Process for preparing 5-(4-fluorophenyl)-1-[2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/14/2006 | US20060205803 1,2 Diarylbenzimidazoles and their pharmaceutical use |
| 09/14/2006 | US20060205802 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 09/14/2006 | US20060205801 Crystal and process for producing the same |
| 09/14/2006 | US20060205800 Glaucoma; prostaglandin EP2 receptor inhibitors |
| 09/14/2006 | US20060205799 Anti-cancer and anti-microbial oxazolidinones |
| 09/14/2006 | US20060205798 Crystal forms of 2-(3-Fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazole-5-ol |
| 09/14/2006 | US20060205797 Compounds for the treatment of inflammatory disorders |
| 09/14/2006 | US20060205796 Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative |
| 09/14/2006 | US20060205795 Cancer treatment with epothilones |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205793 Flupirtine preparation for the treatment of neurodegenerative diseases of the visual apparatus and diabetes mellitus |
| 09/14/2006 | US20060205792 Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| 09/14/2006 | US20060205791 Pharmaceutical process and compounds prepared thereby |
| 09/14/2006 | US20060205790 Medicinal arylethanolamine compounds |
| 09/14/2006 | US20060205789 Gacyclidine formulations |
| 09/14/2006 | US20060205788 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/14/2006 | US20060205787 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1,3-dione |
| 09/14/2006 | US20060205786 New use of iloperidone |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205784 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205783 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 09/14/2006 | US20060205782 Method of providing an antihistaminic effect in a hepatically impaired patient |
| 09/14/2006 | US20060205781 Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/14/2006 | US20060205780 Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 09/14/2006 | US20060205779 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-(5-[4-(3-dimethylaminopropoxy)benzylamino]pentylcarbamoyl)ethyl)piperidin-4-yl ester |
| 09/14/2006 | US20060205778 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205777 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205776 liquid formulation contains at least one organic acid dissolved in a solvent; chemical stability, storage stability, shelf life; treating attention-deficit disorder in children |
| 09/14/2006 | US20060205775 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-[2-((4-[4-(2-hydroxyethylcarbamoyl)piperidin-1-ylmethyl]benzoyl)methylamino)ethyl]piperidin-4-yl ester |
| 09/14/2006 | US20060205774 4-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 09/14/2006 | US20060205773 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205771 Caspase inhibitors as anticancer agents |
| 09/14/2006 | US20060205770 Acid addition salts such as (-)-(3R)-quinuclidin-3-yl(1R)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate (-)-(2S,3S)-tartrate; for treatment of various M3 receptor-mediated diseases such as urinary incontinence, respiratory diseases such as chronic obstructive pulmonary disease |
| 09/14/2006 | US20060205769 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 09/14/2006 | US20060205768 Tropane derivatives and their use as ace inhibitors |
| 09/14/2006 | US20060205767 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 09/14/2006 | US20060205766 Process for making crystalline form I of clopidogrel hydrogen sulphate |
| 09/14/2006 | US20060205765 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents |
| 09/14/2006 | US20060205764 Inhibition of platelet aggregation |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205761 Ccr-2 antagonists for treatment of neuropathic pain |
| 09/14/2006 | US20060205760 Molecules and methods for fluorescence microscopy |
| 09/14/2006 | US20060205759 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 09/14/2006 | US20060205758 Method for reducing the mortality rate |
| 09/14/2006 | US20060205757 39-desmethoxyrapamycin, compositions and methods of use thereof |
| 09/14/2006 | US20060205756 Antitussives |
| 09/14/2006 | US20060205755 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 09/14/2006 | US20060205754 Combination of a serotonin reuptake inhibitors and agomelatine |
| 09/14/2006 | US20060205753 Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction |
| 09/14/2006 | US20060205752 Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid |
| 09/14/2006 | US20060205751 Novel compounds |
| 09/14/2006 | US20060205750 Cardiovascular disorders; central nervous system disorders; metabolic diseases; therapy for eating disorders; trans-2-(2-fluorophenyl)-8-[3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-yl]purine |
| 09/14/2006 | US20060205749 Remedy and/or preventive for lung diseases |
| 09/14/2006 | US20060205747 Non-sedating barbiturate compounds as neuroprotective agents |
| 09/14/2006 | US20060205746 For the treatment of hyperproliferative disorders like actinic keratosis, anogenital warts, seborrhoic keratosis, skin cancer; topical application with good physico-chemical stability, good penetration |
| 09/14/2006 | US20060205745 Microcrystal |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205743 Protein kinase inhibitors |
| 09/14/2006 | US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 09/14/2006 | US20060205741 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 09/14/2006 | US20060205740 Chemical compounds |
| 09/14/2006 | US20060205739 Aroylfuranes and aroylthiophenes |
| 09/14/2006 | US20060205738 Capped pyrazinoylguanidine sodium channel blockers |
| 09/14/2006 | US20060205737 Substituted arylamine compounds and methods of treatment |
| 09/14/2006 | US20060205736 Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| 09/14/2006 | US20060205735 Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonists |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205733 Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
| 09/14/2006 | US20060205731 Novel aminopyridine compounds having Syk inhibitory activity |
| 09/14/2006 | US20060205730 Discovery of valuable properties for the primary energy source "PES 2000 plus folic acid" |